「Receptor」の共起表現一覧(1語右で並び替え)
該当件数 : 1957件
| has extremely high affinity to the ryanodine | receptor, a group of calcium channels found in skeleta |
| It is a noncompetitive antagonist of the AMPA | receptor, a type of glutamate receptor in the central |
| cytoplasm, the steroid binds to the specific | receptor, a large metalloprotein. |
| ol is a potent agonist at the TRPV1 vanilloid | receptor, a weak agonist at both CB1 and CB2 receptors |
| of normal mice with soluble activin type IIB | receptor, a molecule that is normally attached to cell |
| encodes the alpha chain of the interleukin-4 | receptor, a type I transmembrane protein that can bind |
| tein with sequence similarity to the estrogen | receptor, a member of nuclear hormone receptor family |
| GLP-1(7-37), liraglutide activates the GLP-1 | receptor, a membrane-bound cell-surface receptor coupl |
| The 5-HT1A | receptor, a serotonin receptor and type of GPCR, has b |
| IL-7 binds to the IL-7 | receptor, a heterodimer consisting of Interleukin-7 re |
| This gene encodes an apolipoprotein E | receptor, a member of the low density lipoprotein rece |
| Interleukin 17 | receptor A, also known as IL17RA and CDw217 (cluster o |
| ACP1 has been shown to interact with EPH | receptor A2 and EPH receptor B1. |
| ies it has been found to bind to the androgen | receptor about as half as strongly as dihydrotestoster |
| The IL-1 | receptor accessory protein (IL1RAP) is a transmembrane |
| hin in vitro preparations, and can block NMDA | receptor action at a reasonably small concentration. |
| nding, a conformational change induced in the | receptor activates the Gq protein, freeing the Gqα sub |
| inding of an odorant particle on an olfactory | receptor activates a particular G protein (Gαolf), whi |
| example, ADAM10 can cut off part of the HER2 | receptor, activating it. |
| pressin binds to the cell surface vasopressin | receptor, activating a signaling pathway that causes t |
| One effect of 5-HT2A | receptor activation is a reduction in intraocular pres |
| d for glycerophospholipid biosynthesis but on | receptor activation of the phosphoinositide pathway, D |
| ted signal tranduction observed during T cell | receptor activation on T cells. |
| verse agonists in that they conteract overall | receptor activation, but they are different because th |
| ugh vasoconstriction mediated by β-adrenergic | receptor activation, in contrast to the histamine effe |
| The latter interaction leads to | receptor activation, and the transduction of the ligan |
| o agonists in that they contribute to overall | receptor activation, but they are different because th |
| and propose a model to explain drug-mediated | receptor activation. |
| rphosphorylated by PKA following β-adrenergic | receptor activation. |
| ssociation of the α and β subunits results in | receptor activation. |
| Receptor Activator of Nuclear Factor κ B (RANK), also | |
| RANKL ( | Receptor Activator for Nuclear Factor κ B Ligand) is f |
| essed and secreted) are unregulated by RANKL ( | receptor activator of NFκB ligand).[[[Category:All |
| led substance CERA (Continuous Erythropoiesis | Receptor Activator), a new generation of EPO, in a blo |
| d positive for CERA (continuous erythropoitin | receptor activator, a third-generation variant of eryt |
| While allopregnanolone, like other GABAA | receptor active neurosteroids such as allotetrahydrode |
| Neuropilin is a protein | receptor active in neurons. |
| of neurotensin in the regulation of dopamine | receptor activity and glutamate signalling in the brai |
| glioside-GM1 (a modulator of cell surface and | receptor activity) turning it into asialo-GM1 to which |
| It inhibits glycine | receptor activity, which decreases motor function. |
| d to one of three single transmembrane domain | receptor activity-modifying proteins (RAMPs) that are |
| pment of synaptic elements by modulating NMDA | receptor activity. |
| The 5-HT1B | receptor acts on the CNS, where it induces presynaptic |
| arp peak in discharge, which gets less as the | receptor adapts. |
| glycine (and related co-agonists at the NMDA | receptor) added to conventional anti-psychotics have a |
| +)-naloxone ("unnatural" isomer, lacks opioid | receptor affinity so selective for TLR4 inhibition |
| se successfully produced a drug with the high | receptor affinity of naltrexone, but which binds almos |
| κ-opioid agonist with no significant μ-opioid | receptor affinity, herkinorin is a μ-opioid agonist wi |
| hat was found to have significant cannabinoid | receptor affinity, and while AM-679 itself has only mo |
| s a benzodiazepine derivative with high GABAA | receptor affinity, and has anticonvulsant effects. |
| s, N-methylation substantially reduces 5-HT2A | receptor affinity. |
| nce responsible for the opiate's delta opioid | receptor affinity. |
| Since agrin fragments induce acetylcholine | receptor aggregation as well as phosphorylation of the |
| echanism of action is thought to be serotonin | receptor agonism, much like other classic psychedelics |
| s most likely attributable to 5HT2A and 5HT2C | receptor agonism, among others. |
| (KN 38-7271) is a drug which is a cannabinoid | receptor agonist developed by Bayer AG. |
| n α1-adrenoceptor antagonist and as an 5-HT1A | receptor agonist Although an initial report suggested |
| itazar is a peroxisome proliferator-activated | receptor agonist with affinity to PPARα and PPARγ, pro |
| s, likely acting as a non-selective serotonin | receptor agonist and/or releasing agent. |
| y to result from action as a 5-HT2A serotonin | receptor agonist in the brain, a mechanism of action s |
| Sunepitron (CP-93,393) is a combined 5-HT1A | receptor agonist and α2-adrenergic receptor antagonist |
| Lasmiditan is a serotonin | receptor agonist that, like the unsuccessful LY-334,37 |
| WIN 55,212-2 is a potent cannabinoid | receptor agonist which has been found to be a potent a |
| Particularly, mixed kappa | receptor agonist mu antagonist opioid analgesics can c |
| JWH-164 is a synthetic cannabinoid | receptor agonist from the naphthoylindole family. |
| LY-334,370 is a selective 5-HT1F | receptor agonist which was under development by Eli Li |
| ogous to clonidine, another alpha2-adrenergic | receptor agonist used for treatment of opioid withdraw |
| Alniditan is a 5-HT1D | receptor agonist with migraine-preventative effects. |
| requires 10-min preincubations with the P2Y2 | receptor agonist UTP. |
| N-methylamphetamine (OMMA), is a β-adrenergic | receptor agonist of the amphetamine class used as a br |
| Osemozotan (MKC-242) is a selective 5-HT1A | receptor agonist with some functional selectivity, act |
| ril, Dirame, Bay 4503) is a partial mu opioid | receptor agonist and weak mu antagonist analgesic from |
| sequently cipralisant was reassessed as an H3 | receptor agonist in human and rat recombinant systems, |
| INN, code named CVT-3146) is an A2A adenosine | receptor agonist that is a coronary vasodilator. |
| CP 47,497 is a cannabinoid | receptor agonist drug, developed by Pfizer in the 1980 |
| occurring compound Menthol is a weak k-opioid | receptor agonist owing to its antinociceptive effects |
| umeron, Memcor) is a muscarinic acetylcholine | receptor agonist with reasonable selectivity for the M |
| Isoguvacine is a GABAA | receptor agonist used in scientific research. |
| ial success in comparison with other dopamine | receptor agonist anti-parkinsonian compounds. |
| It acts as a D2-like | receptor agonist and also has some serotonin and adren |
| Adrenergic | receptor agonist |
| It is an α1-adrenergic | receptor agonist with some β effect. |
| touted as a preferential postsynaptic 5-HT1A | receptor agonist and is being investigated as a novel |
| Sarizotan (EMD-128,130) is a selective 5-HT1A | receptor agonist and D2 receptor antagonist, which has |
| An adenosine A3 | receptor agonist (CF-101) is in clinical trials for th |
| Alvameline (Lu 25-109) is a M1 | receptor agonist and M2/M3 receptor antagonist that wa |
| tagonist tiletamine or the alpha-2 adrenergic | receptor agonist xylazine, depending on what purpose i |
| the first drug developed that acts as a GABAA | receptor agonist selective for the α4β3δ subtype, whic |
| Bremazocine is a κ-opioid | receptor agonist related to pentazocine. |
| y to result from action as a 5-HT2A serotonin | receptor agonist in the brain, a mechanism of action s |
| d on accident as a derivative of the κ-opioid | receptor agonist U-50,488. |
| ) is a non-selective muscarinic acetylcholine | receptor agonist which acts as a full agonist at the M |
| ne is a moderately selective beta2-adrenergic | receptor agonist that stimulates receptors of the smoo |
| y to result from action as a 5-HT2A serotonin | receptor agonist in the brain, a mechanism of action s |
| y to result from action as a 5-HT2A serotonin | receptor agonist in the brain, a mechanism of action s |
| rgotoliderived) is an ergoline-based dopamine | receptor agonist used in some countries for the treatm |
| y to result from action as a 5-HT2A serotonin | receptor agonist in the brain, a mechanism of action s |
| l homologue, (C8)-CP 47,497) is a cannabinoid | receptor agonist drug, developed by Pfizer in 1979. |
| Flibanserin is a 5-HT1A | receptor agonist and 5-HT2A receptor antagonist that h |
| -chloro-N(6)-cyclopentyladenosine, a specific | receptor agonist for the Adenosine A1 receptor. |
| gluva) is a peroxisome proliferator-activated | receptor agonist with affinity to PPARα and PPARγ. |
| y to result from action as a 5-HT2A serotonin | receptor agonist in the brain, a mechanism of action s |
| 0, TRK-820; trade name Remitch) is a κ-opioid | receptor agonist marketed as a treatment for uremic pr |
| erazinium (DMPP) is a nicotinic acetylcholine | receptor agonist which is selective for the ganglionic |
| mily, and an antidepressant (M1 acetylcholine | receptor agonist). |
| Siramesine (or Lu 28-179) is a sigma | receptor agonist, selective for the σ2 subtype. |
| and instead acts as a selective β-adrenergic | receptor agonist, thereby mediating its bronchodilator |
| found to act as a high affinity α2-adrenergic | receptor agonist, moderate affinity 5-HT1A receptor an |
| Cytisine is a nicotinic acetylcholine | receptor agonist, and as a pharmaceutical preparation, |
| in toxin bufotenidine (5-HTQ), a potent 5-HT3 | receptor agonist, and has been found exclusively in In |
| A partial µ-opioid | receptor agonist, its mixed agonist/antagonist activit |
| For the dopamine D1 | receptor agonist, see 6-Br-APB. |
| (-)-pentazocine is a κ opioid | receptor agonist, while (+)-pentazocine is not, instea |
| gesic drug which acts as a potent cannabinoid | receptor agonist, and was developed by Abbott Laborato |
| ctivity, acting as a balanced μ- and κ-opioid | receptor agonist, while having no effects on δ-opioid |
| ipramol does not, and instead acts as a sigma | receptor agonist, among having other properties. |
| Opipramol acts as a high affinity sigma | receptor agonist, primarily at the σ1 subtype, but als |
| y, LY-285,265) is a potent and selective NMDA | receptor agonist, stimulating the NMDA receptor with h |
| It acts as a potent and selective 5-HT6 | receptor agonist, with a Ki of 1 nM, a significantly h |
| Nabazenil (SP-175) is a synthetic cannabinoid | receptor agonist, which has anticonvulsant properties. |
| cts as a potent and selective cannabinoid CB2 | receptor agonist, based on a quinolone-3-carboxylic ac |
| ts as a potent and selective serotonin 5-HT1B | receptor agonist, with approximately 25x and 40x selec |
| Methoxamine is an α1-adrenergic | receptor agonist, similar in structure to phenylephrin |
| It acts as a σ1 | receptor agonist, κ-opioid receptor agonist, and NMDA |
| Dopamine | receptor agonist, selective for subtypes D2 and D3. |
| g which acts as a potent and selective 5-HT2C | receptor agonist, with an EC50 of 1nM and 15x selectiv |
| Frovatriptan is a 5HT | receptor agonist, with high affinity for the 5-HT1B/1D |
| been found in vitro to act mainly as a 5-HT1A | receptor agonist, with some additionally affinity for |
| ts as a potent and selective serotonin 5-HT1B | receptor agonist, with approximately 150x and 200x sel |
| oid drug, which is a potent and selective CB2 | receptor agonist, with a Ki of 13.0nM and selectivity |
| cylated human glucagon-like peptide-1 (GLP-1) | receptor agonist, with a 97% amino acid sequence homol |
| nylephrine is a direct selective α-adrenergic | receptor agonist, it does not cause the release of end |
| ndogenous ligand is that the ligand will be a | receptor agonist. |
| P 55,244 is a compound which is a cannabinoid | receptor agonist. |
| Ebalzotan (NAE-086) is a selective 5-HT1A | receptor agonist. |
| ddition, it acts as a non-selective serotonin | receptor agonist. |
| Aceclidine acts as a muscarinic acetylcholine | receptor agonist. |
| Bronkometer, is a selective beta2-adrenergic | receptor agonist. |
| Levacetylmethadyl acts as a mu-opioid | receptor agonist. |
| 0 is an analgesic drug which is a cannabinoid | receptor agonist. |
| an analgesic drug which acts as a cannabinoid | receptor agonist. |
| It acts as a 5-HT1B and 5-HT1D | receptor agonist. |
| BAY 60-6583 is a selective adenosine A2B | receptor agonist. |
| tamine derivative drug which acts as a 5-HT2B | receptor agonist. |
| otonic drug which acts as a Beta-1 adrenergic | receptor agonist. |
| CGS-21680 is a specific adenosine A2A subtype | receptor agonist. |
| It acts as a 5-HT1A and 5-HT1B | receptor agonist. |
| This article is about the dopamine D1 | receptor agonist. |
| P-532,903 is a selective adenosine A3 subtype | receptor agonist. |
| Bamaluzole is a GABA | receptor agonist. |
| a serotonin releasing agent and potent 5HT2B | receptor agonist. |
| chemical which acts as a selective D2 and D3 | receptor agonist. |
| It acts as adenosine | receptor agonist. |
| Imetit is a Histamine H3 | receptor agonist. |
| ts derived mainly from its action as a 5-HT1A | receptor agonist. |
| Betazole is a histamine H2 | receptor agonist. |
| hich acts as a potent and selective κ1-opioid | receptor agonist. |
| xert the opposite pharmacological effect of a | receptor agonist. |
| Brimonidine is an α2-adrenergic | receptor agonist. |
| Igmesine (JO-1,784) is a sigma | receptor agonist. |
| opioid analgesic drug, acting as a mu-opioid | receptor agonist. |
| lkylindole family which acts as a cannabinoid | receptor agonist. |
| It has also been found to be a GABAA | receptor agonist. |
| repinephrine release as well, and as a 5-HT2A | receptor agonist. |
| -cancer effects, and action as a kappa opioid | receptor agonist. |
| is a research chemical which is a cannabinoid | receptor agonist. |
| e serotonin releasing agent (SSRA) and 5-HT2A | receptor agonist. |
| Thus, CB2 | receptor agonists are a potential therapeutic target f |
| ertension, bradycardia or using alpha or beta | receptor agonists should consult with their physician |
| These data suggest that mGlu2/3 | receptor agonists have antipsychotic properties and ma |
| NMDA | receptor agonists like ibotenic acid (which is found i |
| GABAA | Receptor Agonists |
| the body as other substances, as if they were | receptor agonists or antagonists, but without binding |
| lopment of new neural nicotinic acetylcholine | receptor agonists will be likely to lead to novel anal |
| Ohmefentanyl is one of the most potent μ | -receptor agonists known, comparable to super-potent o |
| four-member subfamily of the synthetic opioid | receptor agonists and sub-category of opioid anti-diar |
| As), and 5-HT1A agonists, as well as oxytocin | receptor agonists, among others. |
| bethanechol, as well as all other muscarinic | receptor agonists, is contraindicated in patients with |
| rgic agonists, also known as Beta1-adrenergic | receptor agonists, are a class of drugs that bind sele |
| of carbachol, as well as all other muscarinic | receptor agonists, is contraindicated in patients with |
| energic agonists, also known as β2-adrenergic | receptor agonists, are a class of drugs used to treat |
| or glycine receptors, or ionotropic glutamate | receptor agonists. |
| t is possible that a person with the CCR5-Δ32 | receptor allele will not be infected with HIV R5 strai |
| Estrogen | receptor alpha and beta show significant overall seque |
| Interleukin 13 | receptor, alpha 1, also known as IL13RA1 and CD213A1 ( |
| RAR-related orphan | receptor alpha has been shown to interact with EP300 a |
| Estrogen | receptor alpha (ER-α), also known as NR3A1 (nuclear re |
| Liver X | receptor alpha (LXR-alpha) is a nuclear receptor prote |
| RAR-related orphan | receptor alpha (ROR-alpha), also known as NR1F1 (nucle |
| Peroxisome proliferator-activated | receptor alpha (PPAR-alpha), also known as NR1C1 (nucl |
| Gamma-aminobutyric acid (GABA) A | receptor, alpha 5, also known as GABRA5, is a protein |
| Thyroid hormone | receptor alpha (TR-alpha) also known as nuclear recept |
| Retinoid X | receptor alpha (RXR-alpha), also known as NR2B1 (nucle |
| s a heterodimer composed of an interleukin 11 | receptor alpha subunit and an incompletely characteriz |
| Estrogen-related | receptor alpha (ERR-α), also known as NR3B1 (nuclear r |
| Estrogen | receptor alpha (ER-α) and estrogen related receptor al |
| endogenous peroxisome proliferator-activated | receptor alpha (PPAR-α) agonist. |
| It is a heterodimer of the interleukin 5 | receptor alpha subunit and CSF2RB. |
| Interleukin 8 | receptor, alpha |
| Estrogen | receptor alpha |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると
|
検索履歴を保存できる！
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
